Navigation Links
MedEfficiency Awarded VA Contract for Its Total Contact Casting Products
Date:12/13/2011

WHEAT RIDGE, Colo., Dec 13, 2011 /PRNewswire/ -- MedEfficiency, Inc., a medical products company that is focused on the development, manufacturing, and marketing of medical devices for treating chronic wounds and lower extremity fractures, today announced that it has been awarded a Veteran's Administration (VA) Contract.  Under the five year contract, MedEfficiency will be listed as a government-approved vendor. 

MedEfficiency specializes in Total Contact Casting (TCC) products for off-loading diabetic foot wounds also known as diabetic foot ulcers. TCC is considered the gold standard for the treatment of diabetic foot wounds. The TCC, in conjunction with comprehensive wound care protocols, provides a dynamic approach to complete immobilization, which allows the tissue to heal without being disturbed or traumatized by repetitive injury or shear forces. 

The TCC-EZ™ is a fast Total Contact Cast System, developed by MedEfficiency, which is less time consuming and less technique sensitive than traditional TCCs. The system provides a patented innovative mesh cast which constructs a one layered cast, supported by an exclusively designed outer boot that provides additional support and stability for the diabetic foot ulcer patient.

"We are extremely pleased to have been awarded the VA contract," commented Jodie Currie, CEO, MedEfficiency, "We have been providing products to wound care professionals and government healthcare agencies since 2002.  With over one million diabetic patients currently in the VA system, our products provide clinically and cost-effective treatment options. The VA contract award will help to lower costs associated with diabetic foot ulcer treatments."  

 

About MedEfficiency
MedEfficiency, Inc. is a medical products company that is focused on the development, manufacturing, and marketing of medical devices for treating chronic wounds and lower extremity fractures. MedEfficiency specializes in Total Contact Casting (TCC) products, which are considered the gold standard for off-loading diabetic foot ulcers. Multiple Randomized Control Trials (RCT) of TCC indicate predictive patient outcomes ~ 90% heal rate in 6 weeks.  MedEfficiency has developed innovative new products using advanced technology to change the ways these conditions are treated and result in improved clinical outcomes and more cost effective treatments.  To learn more about Diabetic Foot Wounds, please visit www.medefficiency.com/diabetic_foot_wounds.html.

 

 


'/>"/>
SOURCE MedEfficiency, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
6. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
7. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
8. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
9. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
10. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
11. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Australia Ophthalmic Lasers Market Outlook to 2022 Summary ... to 2022", provides key market data on the Australia ... of US dollars, volume (in units) and average prices ... and YAG Lasers. The report also provides company ... market segements, and global corporate-level profiles of the key ...
(Date:12/8/2016)... , Dec. 8, 2016  The global biosurgery ... 8.8% during the forecast period of 2016 to 2021. ... by 2021 from USD 18.21 billion in 2016. The ... rising incidences of sports related injuries and spinal problems, ... rising need of effective blood loss management. ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... largest share of the market in 2016 and is ... can be attributed to a large number of surgical ... hold the largest share in the patient temperature management ... such as reducing loss of blood during surgeries, lowering ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... ... "I have gout, and I wanted to treat it naturally," said an ... relieve gout and pain caused by varicose veins. I drank it every morning for ... what VA doctors called the worst sinusitis case they'd seen and relieved gas, stress ...
(Date:12/9/2016)... ... 2016 , ... Mediaplanet today announces distribution of the latest edition of “Transplants,” ... up as an organ donor for the 123,000 people in the United States who ... save up to 8 saves through organ donation and enhance many others through tissue ...
(Date:12/9/2016)... , ... December 09, 2016 , ... ... through the Pennsylvania Cable Network (PCN) during the summer of 2016. The program ... Grant provided by the United States Department of Health and Human Services Administration. ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
Breaking Medicine News(10 mins):